ArticleInflammatory bowel diseases2019

Sustained Clinical Remission With Vedolizumab in Patients With Moderate-to-Severe Ulcerative Colitis.

Brian G Feagan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.